Long-Term Follow-Up in Children with Steroid-Resistant Nephrotic Syndrome

Clinical Pediatrics

Volumn 31, Issue 5, 1992, Pages 283-288

  Besbas, Nesrin ^a   Saatci, Omit ^a   Bakkaloglu, Aysin ^a   Topaloglu, Rezan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE;

ADOLESCENT; ARTICLE; CHILD; DRUG RESISTANCE; GLOMERULOSCLEROSIS; HEMATURIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOCOMPLEMENTEMIA; KIDNEY BIOPSY; LONG TERM CARE; MAJOR CLINICAL STUDY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; REMISSION; STEROID THERAPY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMAN; INFANT; MALE; NEPHROTIC SYNDROME; PROSPECTIVE STUDIES; REMISSION INDUCTION; STEROIDS; TIME FACTORS;

EID: 0026639404     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/000992289203100504     Document Type: Article

References (29)

1. McEnery PT, Strife CF Nephrotic syndrome in childhood. Pediatr Clin North Am. 1982; 89: 875-894.
2. Rance CP, Arbus GS, Balfe JW Management of the nephrotic syndrome in children. Pediatr Clin North Am. 1976; 23: 735-750.
3. Vernier RL Primary (idiopathic) nephrotic syndrome. In: Holliday MA, Barratt TM, Vernier RL, eds. Pediatric Nephrology. 2nd ed. Baltimore, MD: Williams and Wilkins; 1987: 445-456.
4. International Study of Kidney Disease in Children (ISKD). Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int. 1978; 13: 159-165.
5. Grupe WE Chlorambucil in steroid-dependent nephrotic syndrome. J Pediatr. 1973; 82: 598-606.
6. Barratt TM, Soothill JF Controlled trial of cyclophosphamide in steroid sensitive relapsing nephrotic syndrome of childhood. Lancet. 1970;2: 479-482.
7. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome: report of the International Study of Kidney Disease in Children. Lancet. 1974; 2: 423-427.
8. Elzouki AY, Jaiswal OP Evaluation of chlorambucil therapy in steroid-dependent and cyclophosphamide-resistant children with nephrosis. Pediatr Nephrol. 1990; 4: 459-462.
9. Grupe W.E, Heymann. Cytotoxic drugs in steroid resistant renal disease. Am J Dis Child. 1966; 112: 448-458.
10. Pennisi AJ, Grushkin CM, Lieberman E. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome. Pediatrics. 1976; 57: 948-951.
11. Williams SA, Walker SP, Ingelfmger JR, Grupe WE Long term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. N Engl J Med. 1980; 302: 929-933.
12. International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. A report. J Pediatr. 1981; 98: 561-564.
13. Chesney RW, Novello AC Form of nephrotic syndrome more likely to progress to renal impairment. Pediatr Clin North Am. 1987; 34: 609-627.
14. Strauss J., Zilleruelo G., Freundlich M., Abitol C. Less commonly recognized features of childhood nephrotic syndrome. Pediatr Clin North Am. 1987; 34: 591-607.
15. Trompeter RS Immunosuppressive therapy in the nephrotic syndrome in children. Pediatr Nephrol. 1989;3: 194-200.
16. Siegel NJ, Gur A., Krassner LS, Kashgarian M. Minimal-lesion nephrotic syndrome with early resistance to steroid therapy. J Pediatr. 1975; 87: 377-380.
17. Moncrieff MW, White RHR, Ogg SC, Cameron JS Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J. 1969; 1: 666-671.
18. McEnery PT, McAdams AJ, West CD Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy. Clin Nephrol. 1980;13: 117-124.
19. Hasegawa O., Hondo M., Nakakara T. Methyl prednisolone pulse therapy for membranoproliferative glomerulonephritis (MPGN) in children. Proc 8th Int Cong Nephrol. 1981; Athens.
20. Davis AE III, Schneeberger EE, Grupe WE Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children. Clin Nephrol. 1978; 9: 184-193.
21. Kincaid-Smith P. The treatment of chronic mesengiocapillary glomerulonephritis with impaired renal function. Med J Aust. 1972; 2: 587-592.
22. Brown EA, Upadhyaya K., Hayslett JP The clinical course of mesangial proliferative glomerulonephritis. Medicine. 1980; 58: 295-303.
23. Waldherr R., Gubler MC, Levy M. The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol. 1978; 10: 171-179.
24. Ehrenreich T., Porush JG, Churg J. Treatment of idiopathic membranous nephropathy. N Engl J Med. 1976;295: 741-746.
25. Randall RE, Treng MG, Abukurah AR Responsiveness of adult idiopathic membranous nephropathy to cyclophosphamide. Am Soc Nephrol. 1970; 4: 65-70.
26. Ehrenreich J., Churg J. Pathology of membranous nephropathy. Pathol Ann. 1968;3: 145-186.
27. Mathieson PW, Turner AN, Maidment CGH, Evans DJ Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function. Lancet. 1988; 2: 869-872.
28. Ponticelli C., Zucchelli P., Imbasciah E. Controlled trial of methyl prednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med. 1984; 310: 946-950.
29. Bogdanovic R., Banicevic M., Cvoric A. Testicular function following cyclophosphamide treatment for childhood nephrotic syndrome: long term follow-up study. Pediatr Nephrol. 1990;451-454.